| Issue Date |
Title |
Author(s) |
| 2014 |
An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia |
Huang, Xinfang;Du, Hui;Gu, Jieruo;Zhao, Dongbao;Jiang, Lindi;Li, Xinfu;Zuo, Xiaoxia;Liu, Yi;Li, Zhanguo;Li, Xiangpei;Zhu, Ping;Li, Juan;Zhang, Zhiyi;Huang, Anbin;Zhang, Yuanchao;Bao, Chunde |
| 2017 |
Association Analysis of the MHC in Lupus Nephritis |
Xu, Ricong;Li, Qibin;Liu, Rongjun;Shen, Juan;Li, Ming;Zhao, Minghui;Wang, Meng;Liao, Qijun;Mao, Haiping;Li, Zhijian;Zhou, Na;Yin, Peiran;Li, Yue;Tang, Xueqing;Wu, Tian;Zhong, Zhong;Wang, Yan;Ai, Zhen;Wang, Ou;Chen, Na;Yang, Xiaoqin;Fang, Junbin;Fu, Ping;Gu, Jieruo;Ye, Kun;Chen, Jian;Dai, Lie;Liu, Huafeng;Liu, Zhangsuo;Liao, Yunhua;Wan, Jianxin;Ding, Guohua;Zhao, Jinghong;Zhang, Hao;Fu, Shuxia;Sun, Liangdan;Zhang, Xuejun;Yang, Huanming;Wang, Jian;Wang, Jun;Liu, Jianjun;Li, Yingrui;Yu, Xueqing |
| 16-Sep-2020 |
Can low-dose methotrexate reduce effusion-synovitis and symptoms in patients with mid- to late-stage knee osteoarthritis? Study protocol for a randomised, double-blind, and placebo-controlled trial |
Zhu, Zhaohua;Yu, Qinghong;Leng, Xiaomei;Han, Weiyu;Li, Zhanguo;Huang, Cibo;Gu, Jieruo;Zhao, Yi;Wang, Kang;Li, Tianwang;Mei, Yifang;Xu, Jianhua;Zhang, Zhiyi;Hunter, David;Cicuttini, Flavia;Zeng, Xiaofeng;Ding, Changhai |
| 2009 |
A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China |
Hu, Dawei;Bao, Chunde;Chen, Shunle;Gu, Jieruo;Li, Zhanguo;Sun, Lingyun;Han, Xinghai;Ni, Liqing |
| 2015 |
Cross-sectional comparison of ultrasonography scoring systems for primary Sjogren's syndrome |
Lin, Dongfang;Yang, Weiqiang;Guo, Xinghua;Cao, Junyan;Lv, Qing;Jin, Ou;Wu, Yuqiong;Gu, Jieruo |
| 2019 |
Long-term prognosis of patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study |
Qian, Junyan;Li, Mengtao;Zhang, Xiao;Wang, Qian;Zhao, Jiuliang;Tian, Zhuang;Wei, Wei;Zuo, Xiaoxia;Zhang, Miaojia;Zhu, Ping;Ye, Shuang;Zhang, Wei;Zheng, Yi;Qi, Wufang;Li, Yang;Zhang, Zhuoli;Ding, Feng;Gu, Jieruo;Liu, Yi;Wang, Yanhong;Zeng, Xiaofeng |
| Apr-2022 |
Phase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 years |
Zhang, Fengchun;Zheng, Jie;Li, Yang;Wang, Guochun;Wang, Mingjun;Su, Yin;Gu, Jieruo;Li, Xingfu;Bass, Damon;Chu, Myron;Curtis, Paula;DeRose, Kathleen;Kurrasch, Regina;Lowe, Jenny;Meizlik, Paige;Roth, David A. |
| 2019 |
Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR-PAH study: Baseline characteristics and risk factors |
Zhang, Na;Li, Mengtao;Qian, Junyan;Wang, Qian;Zhao, Jiuliang;Yang, Zhenwen;Tian, Zhuang;Zhang, Xiao;Zuo, Xiaoxia;Zhang, Miaojia;Zhu, Ping;Ye, Shuang;Zhang, Wei;Zheng, Yi;Qi, Wufang;Li, Yang;Zhang, Zhuoli;Ding, Feng;Gu, Jieruo;Liu, Yi;Wei, Wei;Zeng, Xiaofeng |
| 2017 |
Rapid Onset of Response Observed with Certolizumab Pegol in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate: Efficacy and Safety Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study |
Bi, Liqi;Li, Yuhui;He, Lan;Xu, Huji;Gu, Jieruo;Wang, Guochun;Zhang, Zhiyi;Liu, Yi;Boehnlein, Marion;Dunkel, Jochen;Shao, Jing;Harris, Kristina;Li, Zhanguo |
| 2013 |
Safety of infliximab therapy in rheumatoid arthritis patients with previous exposure to hepatitis B virus |
Zhang, Xuewu;Zhang, Fengchun;Wu, Donghai;Bao, Chunde;Zhu, Ping;Zhang, Xiao;Huang, Cibo;He, DongYi;Tao, Yi;Fang, Yongfei;Gu, Jieruo;Wu, Huaxiang;Sun, Lingyun;Yang, Xiuyan;Huang, Feng;Xu, Huji;Zhao, Dongbao;Zhang, Miaojia;Zheng, Yi;Li, Zhanguo |
